Artificial Oxygen Carrier

Artificial Oxygen Carrier-1

K. Kobayashi, E. Tsuchida, H. Horinouchi (Eds.) 2005 Its Front Line Our understanding of blood has changed considerably since the Middle Ages, when it was regarded with a mixture of fear and superstition. The first successful human transfusion was done by James Blundell in 1818, and in the last century, since Karl Landsteiner discovered blood types, transfusion medicine has […]

Continue reading →

Technical Basis of Radiation Therapy

Technical Basis of Radiation Therapy-1

S. H. Levitt · J. A. Purdy · C. A. Perez S. Vijayakumar (Eds.) 2006 Practical Clinical Applications This is the 4th edition of a book which was originally initiated as a supplement to a postgraduate refresher course in radiation oncology held at the University of Minnesota. This program was instituted in 1970 and ended 25 years […]

Continue reading →

Stem Cell and Gene-Based Therapy

Stem Cell and Gene-Based Therapy-1

Alexander Battler and Jonathan Leor 2006 Frontiers in Regenerative Medicine The human body has limited potential to rejuvenate injured organs and tissues. An old dream of scientists and physicians is to be able to rebuild “spare parts” to replace injured or diseased tissues—a notion that was once referred to as the field of science fiction. The new discipline […]

Continue reading →

Pediatric Oncology

Pediatric Oncology-1

Paul Imbach · Thomas Kühne Robert Arceci (Eds.) 2006 A Comprehensive Guide The healing process in children and adolescents with oncological diseases depends greatly on the knowledge and experience of all those involved in the patients’ care: physicians, specialist nurses, psychooncologists and others. This last group embraces parents, siblings and teachers as well as laboratory staff, physiotherapists, pastoral […]

Continue reading →

HODGKIN’S AND NON-HODGKIN’S LYMPHOMA

Hodgkins and Non-Hodgkins Lymphoma-1

Edited by JOHN P. LEONARD MORTON COLEMAN 2006 The lymphomas are the most common malignancies where the tools of the medical oncologist serve as the principal treatment modality and can frequently result in cure of the patient. Over the past several decades, the use of chemotherapy for lymphoma has rapidly evolved to allow for improvements in efficacy as well […]

Continue reading →

HISTORY OF THE EUROPEAN ASSOCIATION FOR HAEMATOPATHOLOGY

History of the European Association for Haematopathology-1

KARL LENNERT 2006 During the last quarter of the 20th century a paradigmatic change occurred in the understanding and classification of malignant lymphomas. This was primarily a result of the discovery of the two lymphocyte systems (the B-cell and T-cell systems with numerous variants), which was made possible mainly through the use of many antibodies, most of which were […]

Continue reading →

Myeloproliferative Disorders

Myeloproliferative Disorders-1

J.V. Melo · J.M. Goldman 2007 So ended the editorial entitled “Some Speculations on the Myeloproliferative Syndomes” published in Blood in 1951 by the journal editor, William Dameshek. He speculated that these various conditions, which he had termed “myeloproliferative,” were all somewhat variable manifestations of proliferative activity of the bone marrow cells, perhaps due to “a hitherto undiscovered […]

Continue reading →